---
title: 'Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates.'
contributors: 'Haddox CL, Nathenson MJ, Mazzola E, Lin JR, Baginska J, Nau A, Weirather JL, Choy E, Marino-Enriquez A, Morgan JA, Cote GM, Merriam P, Wagner AJ, Sorger PK, Santagata S, George S. (2024).'
publication: Clin Cancer Res.
publication_link: https://doi.org/10.1158/1078-0432.CCR-23-2250

image: publications/phase-2-study-Eribulin-plus-Pembrolizumab-metatastatic-soft-tissue-sarcomas.png

group: harvard

date: 2024-01-18

minerva_link:
dataset_link:
pubmed_link: https://pubmed.ncbi.nlm.nih.gov/38236580/
preprint_link:
pdf_link:
show_page_link: false
---
